D12	Co-creation of a tailored U=U (undetectable=untransmittable) message to increase HIV testing in men in Western Cape, South Africa	E-poster	Uptake of HIV testing
B13	Clinically relevant depressive symptoms and initiation of hepatitis C virus (HCV) treatment in the HIV-HCV co-infected population in Canada	E-poster	Viral hepatitis C
D2	Clinical outcomes of community ART distribution: DRC's experience with the PODI+ model	E-poster	Impact evaluation of differentiated service delivery
D9	Clinical outcomes during CUSTOMIZE: a hybrid III implementation-effectiveness study focused on implementation of cabotegravir plus rilpivirine (CAB+RPV) LA in US healthcare settings	E-poster	Feasibility and acceptability of emerging HIV prevention strategies
B33	Clinical impact of antiretroviral agents used in optimized background therapy with fostemsavir in heavily treatment-experienced adults with HIV-1: exploratory analyses of the phase 3 BRIGHTE study	E-poster	ART in highly treatment-experienced people
B78	Clinical characteristics and prognostic factors in people living with HIV hospitalized with COVID-19: findings from the WHO Global Clinical Platform	E-poster	COVID-19 morbidity and mortality in PLWH
D14	Clinical and psychosocial determinants of adherence: results from the MaxART clustered randomized stepped wedge trial of early access to ART	E-poster	Adherence to HIV treatment
D20	Circumventing COVID-19 challenges while expanding access to HIV services: lessons from the Nigeria Antiretroviral Therapy (ART) Surge, February'September 2020	E-poster	Adaptations of HIV treatment services during COVID-19
B26	Circulating GDF15 levels are associated with aging, risk of non-AIDS comorbidities and integrated HIV DNA in ART-treated people living with HIV	E-poster	Ageing with HIV (including polypharmacy and frailty)
A13	Chronic morphine administration alters gut-brain homeostasis in SHIV infected rhesus macaques	E-poster	Virology of CNS compartment